日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cancer-Like Fragmentomic Characteristics of Somatic Variants in Cell-Free DNA

无细胞DNA中体细胞变异的癌症样片段组学特征

Zhang, Zhenyu; An, Yunyun; Yang, Mengqi; Pan, Yuqi; Liu, Xiaoyi; Gong, Fanglei; Lin, Huizhen; Tang, Bianbian; Bai, Yunxia; Zhao, Xin; Zhao, Yu; Du, Changzheng; Sun, Kun

Methionine Metabolism Dictates PCSK9 Expression and Antitumor Potency of PD-1 Blockade in MSS Colorectal Cancer.

蛋氨酸代谢决定 MSS 结直肠癌中 PCSK9 的表达和 PD-1 阻断的抗肿瘤效力

Wang Qi-Long, Chen Zijie, Lu Xiaofei, Lin Huizhen, Feng Huolun, Weng Nuozhou, Chen Liwen, Liu Mengnan, Long Li, Huang Lingjun, Deng Yongmei, Zheng Kehong, Zheng Xiaojun, Li Yong, Cai Ting, Zheng Jiabin, Yang Wei

Sensitive monitoring of xenograft cancer models using cell-free DNA

利用无细胞DNA对异种移植癌模型进行灵敏监测

An, Yunyun; Lin, Huizhen; Tang, Bianbian; Gong, Fanglei; Bai, Yunxia; Zhu, Wenjing; Peng, Qiyu; Sun, Kun

Protocol for the analysis of cell-free DNA end characteristics for accurate cancer diagnosis

用于准确诊断癌症的无细胞DNA末端特征分析方案

Liu, Xiaoyi; Gong, Fanglei; Lin, Huizhen; An, Yunyun; Sun, Kun

Systematic biases in reference-based plasma cell-free DNA fragmentomic profiling

基于参考的血浆游离DNA片段组分析中的系统性偏差

Liu, Xiaoyi; Yang, Mengqi; Hu, Dingxue; An, Yunyun; Wang, Wanqiu; Lin, Huizhen; Pan, Yuqi; Ju, Jia; Sun, Kun

Correction to: Potentiating CD8(+) T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling

更正:通过抑制PCSK9促进LDLR介导的TCR再循环和信号传导,从而增强CD8(+) T细胞的抗肿瘤活性

Yuan, Juanjuan; Cai, Ting; Zheng, Xiaojun; Ren, Yangzi; Qi, Jingwen; Lu, Xiaofei; Chen, Huihui; Lin, Huizhen; Chen, Zijie; Liu, Mengnan; He, Shangwen; Chen, Qijun; Feng, Siyang; Wu, Yingjun; Zhang, Zhenhai; Ding, Yanqing; Yang, Wei

The lnc-CTSLP8 upregulates CTSL1 as a competitive endogenous RNA and promotes ovarian cancer metastasis

lnc-CTSLP8 上调 CTSL1 作为竞争性内源性 RNA 并促进卵巢癌转移

Xinjing Wang #, Xiaoduan Li #, Feikai Lin, Huizhen Sun, Yingying Lin, Ziliang Wang, Xipeng Wang